Immunohistochemistry also revealed overexpression of Mina53 in gastric cancer, colon cancer, esophageal cancer, lymphoma, renal cell carcinoma, and neuroblastoma [18–27]. This evidence concerns the gene RIOX2 and gastric cancer.